Explore the full record of transactions filed by Peter Gilmour, Membre du Conseil. Insider active across 2 companies, notably Guard Therapeutics International AB (publ). Cumulatively, 1 disclosures have been recorded. Activity tracked since 1 April 2025. The latest transaction was filed on 1 April 2025 (Purchase). Regulator: FIN-FSA. All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Peter Gilmour is a board member of Guard Therapeutics International AB (publ). He participates in strategic decisions and oversees the company's operations. His experience in the biotechnology sector contributes to the leadership of Guard Therapeutics.